Our results showed that colitis mice had lower levels of IL-6 and TNF-α after Safranal treatment than 3.5% DSS-treated mice, suggesting that Safranal alleviated the severity of colitis by decreasing IL-6 and TNF-α in colon tissue. The gene discussed is IL6; the disease is colitis.